Is WVE Overvalued?

WVE is now in the Undervalued zone, suggesting that WVE current forward PE ratio of -10.03 is considered Undervalued compare with the five-year average of -4.59.
P/E
EV/EBITDA
P/S
P/B
bubble
P/E

WVE Competitors Valuation Multiple

P/E
EV/EBITDA
P/S

P/E Multiple

Earnings Growth
Market Cap
stocks logo
WVE.O
WAVE Life Sciences Ltd
loss
Average P/E: 17.15
-812.71%
1.54B
stocks logo
IMCR.O
Immunocore Holdings PLC
loss
1.48B
stocks logo
KMDA.O
Kamada Ltd
23.80
24.82%
396.78M
stocks logo
ANIP.O
ANI Pharmaceuticals Inc
10.50
-1612.78%
1.46B
stocks logo
DYN.O
Dyne Therapeutics Inc
loss
19.13%
1.27B
stocks logo
GLPG.O
Galapagos NV
loss
1.66B

WVE Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

WVE FAQs

Is WVE currently overvalued based on its P/E ratio?

According to the provided data, WVE's 5-year historical average forward P/E ratio is -4.59. WVE forward P/E ratio is -10.03, which is categorized as Undervalued.

What is the significance of the EV/EBITDA ratio for WVE?

How has WVE's Price to Sales (PS) ratio evolved?

What are the key indicators to watch for WVE's financial performance?

WVE PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
Undervalued
5Y Average PE
-4.59
Current PE
-10.03
Overvalued PE
-1.50
Undervalued PE
-7.68

WVE EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
Undervalued
5Y Average EV
-1.99
Current EV
-6.65
Overvalued EV
1.15
Undervalued EV
-5.13

WVE P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
Overvalued
5Y Average PS
11.74
Current PS
21.56
Overvalued PS
19.85
Undervalued PS
3.64

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is WVE undervalued?Is WVE overvalued compared to its competitors?